NALFURAPRANT

Serial Number 98438274
819

Registration Progress

Application Filed
Mar 7, 2024
Under Examination
Feb 11, 2025
Approved for Publication
Dec 17, 2024
Published for Opposition
Dec 17, 2024
Registered

Trademark Image

NALFURAPRANT

Basic Information

Serial Number
98438274
Filing Date
March 7, 2024
Published for Opposition
December 17, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
819
Status Date
Sep 2, 2025
Application
Pending
Classes
005

Rights Holder

Jaywing Therapeutics

16
Address
8530 Sand Point Way NE
Seattle, WA 98115-3950

Ownership History

Jaywing Therapeutics

Original Applicant
16
Seattle, WA

Jaywing Therapeutics

Owner at Publication
16
Seattle, WA

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

27 events
Date Code Type Description Documents
Sep 3, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Sep 2, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Aug 7, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 7, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 24, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 8, 2025 GNRT O NON-FINAL ACTION E-MAILED Loading...
May 8, 2025 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
May 8, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 23, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 23, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Feb 11, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 11, 2025 IUAF S USE AMENDMENT FILED Loading...
Feb 11, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Dec 17, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 17, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 11, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 21, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 21, 2024 ALIE A ASSIGNED TO LIE Loading...
Nov 20, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 20, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 22, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 20, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 20, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 20, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 20, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 7, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 7, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment and prevention of addiction, psychosis
First Use Anywhere: Mar 11, 2024
First Use in Commerce: Jan 8, 2025

Classification

International Classes
005